Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (±)-Pranoprofen

(±)-Pranoprofen

pharmaceutical raw materials
(±)-Pranoprofen structure

(±)-Pranoprofen 

structure
  • CAS No:

    52549-17-4

  • Formula:

    C15H13NO3

  • Chemical Name:

    (±)-Pranoprofen

  • Synonyms:

    5H-[1]Benzopyrano[2,3-b]pyridine-7-acetic acid,α-methyl-;α-Methyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetic acid;Y 8004;2-(5H-[1]-Benzopyrano[2,3-b]pyridin-7-yl)propionic acid;Pranoprofen;Niflan;α-Methyl-5H-[1]benzopyrano[2,3-b]pyridine-7-ylacetic acid;(±)-Pranoprofen;(RS)-Pranoprofen;dl-Pranoprofen;Oftalar;2-(5H-Chromeno[2,3-b]pyridin-7-yl)propanoic acid;103813-86-1

  • Categories:

    Active Pharmaceutical Ingredients  >  Antipyretic Analgesics

Description

Pranoprofen is a non-steroidal anti-inflammatory drug used in ophthalmology. Target: PGE2Pranoprofen 0.1% was found to be as effective as diclofenac sodium 0.1% in reducing inflammation and pain after strabismus surgery. Pranoprofen could be used as a safe and effective anti-inflammatory alternative for the treatment of inflammation following strabismus surgery [1]. pranoprofen has efficacy equivalent to a moderate-potency corticosteroid with a better safety profile. It should be conside


Pranoprofen is a pyridochromene.

(±)-Pranoprofen Basic Attributes

255.27

255.27

1308068-626-2

759832

DTXSID1023497

S01BC09|S - Sensory organs

2934999090

Characteristics

59.4

2.7

1.3±0.1 g/cm3

182-183 °C

465.7°C at 760 mmHg

235.5±25.4 °C

1.628

LD50 in male mice, rats (mg/kg): 447.3, 87.3 orally (Edanaga)

Safety Information

UN 2811 6.1 / PGIII

DJ3100950

P301 + P310 + P330

H301

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)|Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

2-(5H-(1)benzopyrano(2,3-b)pyridin-7-yl)propionic acid

(±)-Pranoprofen Use and Manufacturing

Anti-inflammatory used in ophthalmology.

Computed Properties

Molecular Weight:255.27
XLogP3:2.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:255.08954328
Monoisotopic Mass:255.08954328
Topological Polar Surface Area:59.4
Heavy Atom Count:19
Complexity:346
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Extract from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Wuhan Leadpharm Pharmaceutical Technology Co., Ltd.

    China China
    Active
  • Gansu Haotian PharmaTech Co., Ltd.

    China China
    Active
  • Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

    China China
    Active

Recommended Suppliers of (±)-Pranoprofen

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.